Cargando…

Animal Models of Chorioamnionitis: Considerations for Translational Medicine

Preterm birth is defined as any birth occurring before 37 completed weeks of gestation by the World Health Organization. Preterm birth is responsible for perinatal mortality and long-term neurological morbidity. Acute chorioamnionitis is observed in 70% of premature labor and is associated with a he...

Descripción completa

Detalles Bibliográficos
Autores principales: Raia-Barjat, Tiphaine, Digonnet, Margaux, Giraud, Antoine, Ayash, Taghreed, Vancolen, Seline, Benharouga, Mohamed, Chauleur, Céline, Alfaidy, Nadia, Sébire, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032938/
https://www.ncbi.nlm.nih.gov/pubmed/35453561
http://dx.doi.org/10.3390/biomedicines10040811
_version_ 1784692768027705344
author Raia-Barjat, Tiphaine
Digonnet, Margaux
Giraud, Antoine
Ayash, Taghreed
Vancolen, Seline
Benharouga, Mohamed
Chauleur, Céline
Alfaidy, Nadia
Sébire, Guillaume
author_facet Raia-Barjat, Tiphaine
Digonnet, Margaux
Giraud, Antoine
Ayash, Taghreed
Vancolen, Seline
Benharouga, Mohamed
Chauleur, Céline
Alfaidy, Nadia
Sébire, Guillaume
author_sort Raia-Barjat, Tiphaine
collection PubMed
description Preterm birth is defined as any birth occurring before 37 completed weeks of gestation by the World Health Organization. Preterm birth is responsible for perinatal mortality and long-term neurological morbidity. Acute chorioamnionitis is observed in 70% of premature labor and is associated with a heavy burden of multiorgan morbidities in the offspring. Unfortunately, chorioamnionitis is still missing effective biomarkers and early placento- as well as feto-protective and curative treatments. This review summarizes recent advances in the understanding of the underlying mechanisms of chorioamnionitis and subsequent impacts on the pregnancy outcome, both during and beyond gestation. This review also describes relevant and current animal models of chorioamnionitis used to decipher associated mechanisms and develop much needed therapies. Improved knowledge of the pathophysiological mechanisms underpinning chorioamnionitis based on preclinical models is a mandatory step to identify early in utero diagnostic biomarkers and design novel anti-inflammatory interventions to improve both maternal and fetal outcomes.
format Online
Article
Text
id pubmed-9032938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90329382022-04-23 Animal Models of Chorioamnionitis: Considerations for Translational Medicine Raia-Barjat, Tiphaine Digonnet, Margaux Giraud, Antoine Ayash, Taghreed Vancolen, Seline Benharouga, Mohamed Chauleur, Céline Alfaidy, Nadia Sébire, Guillaume Biomedicines Review Preterm birth is defined as any birth occurring before 37 completed weeks of gestation by the World Health Organization. Preterm birth is responsible for perinatal mortality and long-term neurological morbidity. Acute chorioamnionitis is observed in 70% of premature labor and is associated with a heavy burden of multiorgan morbidities in the offspring. Unfortunately, chorioamnionitis is still missing effective biomarkers and early placento- as well as feto-protective and curative treatments. This review summarizes recent advances in the understanding of the underlying mechanisms of chorioamnionitis and subsequent impacts on the pregnancy outcome, both during and beyond gestation. This review also describes relevant and current animal models of chorioamnionitis used to decipher associated mechanisms and develop much needed therapies. Improved knowledge of the pathophysiological mechanisms underpinning chorioamnionitis based on preclinical models is a mandatory step to identify early in utero diagnostic biomarkers and design novel anti-inflammatory interventions to improve both maternal and fetal outcomes. MDPI 2022-03-30 /pmc/articles/PMC9032938/ /pubmed/35453561 http://dx.doi.org/10.3390/biomedicines10040811 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Raia-Barjat, Tiphaine
Digonnet, Margaux
Giraud, Antoine
Ayash, Taghreed
Vancolen, Seline
Benharouga, Mohamed
Chauleur, Céline
Alfaidy, Nadia
Sébire, Guillaume
Animal Models of Chorioamnionitis: Considerations for Translational Medicine
title Animal Models of Chorioamnionitis: Considerations for Translational Medicine
title_full Animal Models of Chorioamnionitis: Considerations for Translational Medicine
title_fullStr Animal Models of Chorioamnionitis: Considerations for Translational Medicine
title_full_unstemmed Animal Models of Chorioamnionitis: Considerations for Translational Medicine
title_short Animal Models of Chorioamnionitis: Considerations for Translational Medicine
title_sort animal models of chorioamnionitis: considerations for translational medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032938/
https://www.ncbi.nlm.nih.gov/pubmed/35453561
http://dx.doi.org/10.3390/biomedicines10040811
work_keys_str_mv AT raiabarjattiphaine animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine
AT digonnetmargaux animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine
AT giraudantoine animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine
AT ayashtaghreed animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine
AT vancolenseline animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine
AT benharougamohamed animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine
AT chauleurceline animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine
AT alfaidynadia animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine
AT sebireguillaume animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine